Petmed Express Inc (PETS)
Drugs • Health Care
July 30, 2026 PetMed Express Inc. to Release First Quarter Fiscal Year 2027 Financial Results PetMed Express, Inc. will announce its financial results for Q1 FY 2027 on August 13, 2026. Investors are keen to see how the company has adapted to online sales trends and demand for pet healthcare. The earnings call will further discuss strategic initiatives and future guidance.
July 23, 2026 PetMeds Announces $37 Million Sale-Leaseback of Headquarters and Distribution Center PetMeds has announced a $37 million sale-leaseback of its headquarters and distribution center to improve financial flexibility. The deal, expected to close within 120 days, aims to strengthen the company's balance sheet and focus on core operations.
July 14, 2026 PetMed Express Partners with Rural King to Enhance Pet Healthcare Access PetMed Express has launched a co-branded online pharmacy with Rural King, providing easy access to pet health products. The initiative aims to enhance convenience and affordability, especially in rural areas, with promotional discounts for customers.
June 30, 2026 PetMed Express Inc. Receives New Acquisition Proposal from SilverCape Investments PetMed Express, Inc. has received a $3.00 per share acquisition proposal from SilverCape Investments. The Board is assessing this unsolicited offer while maintaining focus on maximizing shareholder value. Stakeholders await updates as negotiations progress.
June 02, 2026 PetMed Express Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2026 PetMed Express, Inc. reported a significant decline in sales for Q4 and fiscal year 2026, with a net loss of $57.3 million. Despite challenges, the company aims to improve operations and customer retention while remaining open to future acquisition offers.
June 02, 2026 PetMed Express Inc. Reports Challenging Fiscal Year 2026 Results PetMed Express, a prominent pet pharmacy, reported a 21% revenue decline for FY 2026, totaling $179 million. The company faced increased operational costs and legal scrutiny, impacting its financial health and customer acquisition efforts significantly. Management is focusing on strategic initiatives to stabilize the business.
May 29, 2026 PetMed Express, Inc. Set to Unveil Fourth Quarter and Fiscal Year 2026 Financial Results PetMed Express, Inc. will announce its fourth quarter and fiscal year 2026 financial results on June 2, 2026. Investors can join a conference call for detailed insights into the company's performance and strategies. The company is a leader in the pet healthcare market, committed to enhancing pet wellness through its extensive offerings.
April 22, 2026 PetMeds Partners with Rural King to Launch New Pet Pharmacy Offering PetMeds has partnered with Rural King to launch a new pet pharmacy, improving access to medications and health products for pet owners, especially in rural areas. This collaboration aims to enhance customer experience and expand PetMeds' reach in underserved communities.
February 05, 2026 PetMed Express Inc. Reports Challenging Q3 2026 Results Amidst Economic Headwinds PetMed Express, a leading pet pharmacy, reported a 23.3% drop in Q3 2026 sales amidst economic challenges, leading to a net loss of $10.55 million. The company is adapting its strategies for better customer acquisition while facing increased operational costs and liquidity pressures.
December 19, 2025 PetMed Express Inc. Reports Significant Financial Challenges in Q2 2026 PetMed Express Inc. reported significant financial losses in Q2 2026, including an $8.52 million net loss and a 25.5% decline in sales. The company is reevaluating its strategies to combat economic challenges while focusing on liquidity and customer engagement.
December 11, 2025 PetMed Express Inc. Responds to Acquisition Proposal from SilverCape Investments PetMed Express has received a non-binding acquisition proposal from SilverCape Investments for $4 per share. The Board is reviewing the offer with advisors, emphasizing a commitment to shareholder interests. The proposal's transparency is significant for market reactions and stakeholder engagement.
December 10, 2025 PetMeds Unveils Holiday Collection Focused on Pet Wellness PetMeds has launched its 2025 Holiday Collection, shifting focus to wellness-oriented gifts for pets. The collection includes grooming products, health kits, and unique items for pet lovers, ensuring a joyful holiday for furry friends.
November 26, 2025 PetMed Express Inc. Extends Shareholder Rights Plan Amid Stock Valuation Concerns PetMed Express, Inc. has extended its shareholder rights plan to December 2026 to protect investor interests amid stock valuation concerns. The Board's decision aims to prevent hostile takeovers while ensuring all shareholders receive equitable treatment.
November 13, 2025 PetMed Express Inc. Faces Compliance Challenges Amid Preliminary Second Quarter Results PetMed Express, Inc. has announced preliminary second-quarter results showing significant declines in net sales and received a non-compliance notice from Nasdaq. The company is addressing its filing delays while facing potential impairment charges, impacting its financial stability and investor confidence.
October 20, 2025 PetMed Express Inc. Welcomes James LaCamp as New Director and Audit Committee Chair PetMed Express has appointed James LaCamp as a new Director and Chair of the Audit Committee. With extensive experience in finance and corporate governance, LaCamp's role is crucial for the company's growth and transparency in the competitive pet healthcare market.
October 14, 2025 PetMed Express Inc. Reports 2025 Annual Results Amidst Governance Overhaul PetMed Express Inc. faced a challenging fiscal year 2025, reporting a 17.2% revenue decline amid governance changes due to a major investigation. Key leadership transitions occurred, and the company is focused on improving operational efficiency and customer retention.
October 14, 2025 PetMed Express Inc. Files Form 10-K for Fiscal 2025: A Deep Dive into Financials and Future Outlook PetMed Express, Inc. filed its 10-K for fiscal 2025, reporting net sales of $227 million and a net loss of $6.3 million. Despite challenges, leadership is optimistic about future growth and restoring regular reporting.
October 08, 2025 PetMed Express, Inc. Announces Inducement Grant for New CISO PetMed Express has awarded 15,000 shares of restricted stock to Ali Khan, their new Chief Information Security Officer, to strengthen cybersecurity. This inducement grant underlines their commitment to attracting top talent in response to increasing digital threats.
March 02, 2025 SWOT Analysis of PetMed Express Inc. in 2025 This SWOT analysis of PetMed Express Inc. explores its strategic position in 2025, focusing on its strengths like brand loyalty and product range, weaknesses such as regulatory risks, and opportunities in the expanding pet wellness market. The analysis underscores the need to navigate competitive pressures while leveraging growth avenues.
February 10, 2025 PetMed Express Inc. Reports Q3 2025 Financial Results: A Strategic Reset Amid Challenges PetMed Express, Inc. reported a significant revenue drop in Q3 2025, down 18.9% from the previous year, as it adjusts its marketing strategies amid macroeconomic challenges. The company is focusing on sustainable profitability and re-evaluating its product offerings while navigating inflation and supply chain disruptions.
February 10, 2025 PetMed Express Inc. Reports Strong Third Quarter Fiscal 2025 Results PetMed Express reported strong financial results for Q3 FY2025, with net sales of $53 million and improved gross margins. The company is focused on operational efficiency and strategic growth, as highlighted by CEO Sandra Campos during their upcoming conference call.
November 07, 2024 PetMed Express Inc. Reports Q2 2025 Financial Results: A Mixed Bag of Progress and Challenges PetMed Express Inc. released its Q2 2025 financial results, showing a recovery in net income but a significant decline in sales. The company is adjusting its strategy, including suspending dividends, to focus on growth initiatives amid a competitive market.
August 07, 2024 PetMed Express Inc. Reports Q1 2025 Financial Results: A Turnaround in Progress PetMed Express Inc. shows signs of recovery in its Q1 2025 financial results, reporting a net income of $3.75 million despite a slight revenue dip. Strategic management changes and a focus on operational efficiency position the company for future growth.
June 14, 2024 PetMed Express Inc. Reports Fiscal Year 2024 Results: Challenges Amidst Growth PetMed Express Inc. reported a 9.5% sales increase in FY 2024, largely due to its acquisition of PetCareRx. However, rising costs led to a significant net loss of $7.5 million and the suspension of dividends, highlighting financial challenges ahead.